Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
insulin aspart 100 units/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
aprotinin 500 000 KI units/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
irinotecan 43 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
tirofiban 12.5 mg/250 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Q fever skin test injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
carfilzomib 30 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iohexol 388 mg (iodine 180 mg)/mL injection, 10 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iotalamate meglumine 600 mg (iodine 280 mg)/mL injection, 50 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 550 mg (iodine 270 mg)/mL injection, 150 mL bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 550 mg (iodine 270 mg)/mL injection, 150 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 652 mg (iodine 320 mg)/mL injection, 150 mL bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 550 mg (iodine 270 mg)/mL injection, 200 mL bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iotalamate meglumine 600 mg (iodine 280 mg)/mL injection, 20 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
fomepizole 1.5 g/1.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 550 mg (iodine 270 mg)/mL injection, 200 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 652 mg (iodine 320 mg)/mL injection, 100 mL bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 652 mg (iodine 320 mg)/mL injection, 150 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 550 mg (iodine 270 mg)/mL injection, 100 mL bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
iodixanol 652 mg (iodine 320 mg)/mL injection, 200 mL bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cisatracurium 50 mg/25 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
pegvisomant 15 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
pegvisomant 10 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
pegvisomant 20 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
measles 1000 TCID50 units + mumps 20 000 TCID50 units + rubella 1000 TCID50 units + varicella-zoster 9772 PFU live vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Granisetron (Apo) 3 mg/3 mL injection, 3 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
idarubicin hydrochloride 20 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
furosemide 250 mg/25 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
adalimumab 40 mg/0.4 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
adalimumab 40 mg/0.4 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alpha-1-proteinase inhibitor 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
teduglutide 5 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
darbepoetin alfa 500 microgram/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sulesomab 310 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride 10 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
follitropin beta 150 international units / 0.18 mL injection, 0.18 mL cartridge (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
somatropin 400 microgram injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
amoxicillin 500 mg + clavulanic acid 100 mg injection, 600 mg vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
amoxicillin 1 g + clavulanic acid 200 mg injection, 1.2 g vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
amoxicillin 2 g + clavulanic acid 200 mg injection, 2.2 g vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
adalimumab 40 mg/0.8 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
piperacillin 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
piperacillin 2 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
piperacillin 4 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor VIII 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
insulin neutral human 100 units/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hepatitis A + hepatitis B adult vaccine injection, 1 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor VIII 1000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hepatitis A virus antigen 360 ELISA units + hepatitis B surface antigen 10 microgram injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
factor VIII 250 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
darbepoetin alfa 15 microgram/0.38 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
darbepoetin alfa 200 microgram/0.4 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
darbepoetin alfa 300 microgram/0.6 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lonoctocog alfa 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
normal immunoglobulin 30 g/500 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
linezolid 400 mg/200 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
basiliximab 10 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lonoctocog alfa 3000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lonoctocog alfa 2500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
interferon beta-1a 12 million units (60 microgram) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lonoctocog alfa 1000 international units injection, 1000 international units vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lonoctocog alfa 1500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
linezolid 200 mg/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lonoctocog alfa 2000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sebelipase alfa 2 mg/mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
zoledronic acid 4 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ustekinumab 130 mg/26 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
radium (223Ra) dichloride 6.6 MBq/6 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 400 mg/200 mL + fentanyl 400 microgram/200 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 150 mg/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 400 mg/200 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 200 mg/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 200 mg/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 75 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 50 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 200 mg/100 mL + fentanyl 400 microgram/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 100 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 40 mg/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 200 mg/100 mL + fentanyl 200 microgram/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 400 mg/200 mL + fentanyl 800 microgram/200 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 20 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
insulin aspart 30 units/mL + insulin aspart protamine 70 units/mL pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
rurioctocog alfa pegol 250 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
rurioctocog alfa pegol 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
rurioctocog alfa pegol 1000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
rurioctocog alfa pegol 2000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ioversol 678 mg (iodine 320 mg)/mL injection, 200 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ioversol 741 mg (iodine 350 mg)/mL injection, 20 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ioversol 741 mg (iodine 350 mg)/mL injection, 200 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ioversol 741 mg (iodine 350 mg)/mL injection, 150 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 100 mg/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sebelipase alfa 20 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 500 mL bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 500 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
catridecacog 2500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
atezolizumab 1.2 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
evolocumab 420 mg / 3.5 mL injection, 3.5 mL cartridge (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
dibasic sodium phosphate dodecahydrate 3.84 g/20 mL + monobasic potassium phosphate 348 mg (potassium 2.6 mmol)/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ramucirumab 500 mg/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|